On October 18th, the US Department of Justice (DOJ), on behalf of the Food and Drug Administration (FDA), filed appeals with federal district courts to seek permanent injunctions against six electronic cigarette manufacturers. These cases mark the first time that the FDA has initiated injunction proceedings to enforce the pre-market review requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act for new tobacco products.
The FDA has stated that despite warning them earlier about violating the law.
The ban will require these companies and designated individuals to stop manufacturing, selling, and distributing their e-cigarettes. "Today's enforcement action is an important step by the FDA in preventing tobacco product manufacturers from breaking the law," said Brian King, director of the FDA's Center for Tobacco Products. "We will not stand idly by as manufacturers repeatedly violate the law, especially after being given multiple opportunities to comply.
The Department of Justice has taken legal action in court under the FD&C Act. As a result, DOJ representatives are filing injunctions on behalf of the FDA in their respective U.S. district courts against the following defendants:
Morin Enterprises Inc. operates an electronic cigarette shop in Minnesota.
Soul Vapor LLC is located in Southern West Virginia.
Super Vape'z LLC in the west district of Washington.
Georgia-based Steam Craft LLC.
Lucky's Convenience & Tobacco LLC, doing business as Lucky's Vape & Smoke Shop located in Kansas.
Seditious Vapors LLC d/b/a Butt Out, located in the state of Arizona.
The FDA has stated that the defendant continued to manufacture, sell, and distribute unauthorized electronic cigarettes to consumers even after receiving a warning letter from the agency. The FDA's prior warning indicated that further non-compliance could result in enforcement actions, including a ban.
These cases are an important step in preventing the illegal sale of unauthorized electronic nicotine delivery system products," said Brian M. Boynton, head of the Civil Division of the Department of Justice and Chief Deputy Assistant Attorney General. "The Department of Justice will continue to closely collaborate with the FDA in order to prevent the distribution of illegal and unauthorized tobacco products.
When a company produces and distributes unauthorized tobacco products, the FDA typically issues a warning letter first to achieve voluntary compliance with the law. If the FDA records continued violations, the agency may request DOJ to take enforcement actions, such as a ban or seizure.
The FDA has the authority to impose administrative and civil penalties for violations of the FD&C Act related to tobacco products.
Statement:
This article is compiled from third-party information and is intended only for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The article's translation is only intended for communication and research within the industry.
Due to limitations in translation abilities, this translated article may not fully reflect the intended meaning of the original text. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau and Taiwan-related or international statements and positions.
The compilation of information belongs to the original media organization and author. If there is any copyright infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
